Impact of the COVID-19 pandemic on outpatient endocrinology consultation and teleconsultation in a Peruvian hospital
DOI:
https://doi.org/10.35434/rcmhnaaa.2022.153.1407Keywords:
Teleconsultation, Endocrinology, Diabetes Mellitus, Hypothyroidism, COVID-19, PeruAbstract
Background: The COVID-19 pandemic affected the continuity of face-to-face medical consultations, so strategies, such as teleconsultations, were implemented to close the gaps in care. The objective of this study was to describe the impact of the pandemic in the traditional endocrinology consultation at Hospital Nacional Alberto Sabogal Sologuren (Callao, Peru). Materials and methods: We carried out a descriptive study of analysis of secondary data, that was obtained from the Sistema de Salud Inteligente of the Social Security of Peru. Data from outpatient consultations between May 2019 and November 2021 were analyzed. Results: Due to the pandemic, the proportion of face-to-face consultations decreased from 100% (pre-pandemic period) to 29,4% (during the pandemic), while teleconsultations predominated after its implementation. More than 68% of patients were women, in face-to-face consultations the median age before and during the pandemic was 59 and 56 years, respectively, while in teleconsultations it was 58 years. Diabetes mellitus was the main reason for consultation (between 32,6% and 34,4% of all consultations), followed by hypothyroidism and nodular thyroid disease. During the pandemic, the proportion of consultations for hypothyroidism was higher in teleconsultations vs. face-to-face consultations (25,3% vs. 18%). Conclusions: During the pandemic, teleconsultations predominated over face-to-face consultation. There were no relevant differences in median age or predominant gender among patients before or during the pandemic. Diabetes mellitus was the main reason for consultation in general and during the pandemic consultations for hypothyroidism were higher in teleconsultation.
Downloads
Metrics
References
Anjana RM, Pradeepa R, Deepa M, Jebarani S, Venkatesan U, Parvathi SJ, et al. Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from Lockdown. Diabetes Technol Ther. 2020;22(7):527–34. Doi: 10.1089/dia.2020.0240.
Monaghesh E, Hajizadeh A. The role of telehealth during COVID-19 outbreak: A systematic review based on current evidence. BMC Public Health. 2020;20(1). Doi: 10.1186/s12889-020-09301-4.
Seclen SN, Rosas ME, Arias AJ, Huayta E, Medina CA. Prevalence of diabetes and impaired fasting glucose in Peru: report from PERUDIAB, a national urban population-based longitudinal study. BMJ Open Diabetes Res Care. 2015;3(1):e000110. Doi: 10.1136/bmjdrc-2015-000110.
Zhu L, She Z-G, Cheng X, Qin J-J, Zhang X-J, Cai J, et al. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab. 2020;31(6):1068-1077.e3. Doi: 10.1016/j.cmet.2020.04.021.
Lopez-Huamanrayme E, Garate-Chirinos DD, Espinoza-Morales F, Del-Castillo-Ochoa S, Gomez-Noronha A, Salsavilca-Macavilca E, et al. Association between hyperglycemia treatment and mortality in patients with diabetes and COVID-19 in a Peruvian hospital: A retrospective cohort study. J Clin Transl Endocrinol. 2021;26:100265. Doi: 10.1016/j.jcte.2021.100265.
Fieux M, Duret S, Bawazeer N, Denoix L, Zaouche S, Tringali S. Telemedicine for ENT: Effect on quality of care during Covid-19 pandemic. Eur Ann Otorhinolaryngol Head Neck Dis. 2020;137(4):257–61. Doi: 10.1016/j.anorl.2020.06.014.
Kludacz-Alessandri M, Hawrysz L, Korneta P, Gierszewska G, Pomaranik W, Walczak R. The impact of medical teleconsultations on general practitioner-patient communication during COVID- 19: A case study from Poland. PLoS One. 2021;16(7):e0254960. Doi: 10.1371/JOURNAL.PONE.0254960.
Alvarez-Risco A, Del-Aguila-Arcentales S, Yáñez JA, Alvarez-Risco A. Telemedicine in Peru as a Result of the COVID-19 Pandemic: Perspective from a Country with Limited Internet Access. Am J Trop Med Hyg. 2021;105(1):6–11. Doi: 10.4269/AJTMH.21-0255.
Seguro Social de Salud (EsSalud). Farmacia vecina, novedoso sistema de EsSalud para el recojo de medicamentos cerca de casa - Essalud [Internet]. 2020 [citado el 13 de junio de 2022]. Disponible en: https://bit.ly/3tdkRUp.
Seguro Social Perú (EsSalud). Directiva de Gerencia General N° 12 “Telemedicina en pacientes con Enfermedad Crónica o Continuador en ESSALUD” [Internet]. 2020 [citado el 11 de diciembre de 2021]. Disponible en: https://bit.ly/3T8ebSl.
Ministerio de Salud Perú (MINSA). Norma Técnica de Salud para el uso de los Equipos de Protección Personal por los trabajadores de las Instituciones Prestadoras de Servicios de Salud [Internet]. Lima; 2020 [citado el 17 de enero de 2022]. Disponible en: https://bit.ly/3DKt3kb
Ministerio de Salud Perú (MINSA). Norma Técnica de Salud para la atención de salud ambulatoria, quirúrgica electiva, en hospitalización y servicios médicos de apoyo, frente a la pandemia por COVID-19 en el Perú [Internet]. Lima; 2021 [citado el 17 de enero de 2022]. Disponible en: https://bit.ly/3NKEjBn
Hincapié MA, Gallego JC, Gempeler A, Piñeros JA, Nasner D, Escobar MF. Implementation and Usefulness of Telemedicine During the COVID-19 Pandemic: A Scoping Review. J Prim Care Community Health. 2020;11:1–7. Doi: 10.1177/2150132720980612.
Curioso WH, Galán-Rodas E. El rol de la telesalud en la lucha contra el COVID-19 y la evolución del marco normativo peruano. Acta Médica Peru. 2020;37(3):366–75. Doi: 10.35663/AMP.2020.373.1004.
Ceccato F, Voltan G, Sabbadin C, Camozzi V, Merante Boschin I, Mian C, et al. Tele-medicine versus face-to-face consultation in Endocrine Outpatients Clinic during COVID-19 outbreak: a single-center experience during the lockdown period. J Endocrinol Invest. 2021;44(8):1689–98. Doi: 10.1007/S40618-020-01476-2.
Anderson D, Porto A, Koppel J, Macri G, Wright M. Impact of Endocrinology eConsults on Access to Endocrinology Care for Medicaid Patients. Telemed e-Health. 2020;26(11):1383–90. Doi: 10.1089/TMJ.2019.0238.
Madduri S, Chowdhary R, Reddy SS. Telehealth Adoption Among Endocrinologists During The Covid-19 Pandemic. Endocr Pract. 2020;26(8):846. Doi: 10.4158/EP-2020-0237.
Alva-Arroyo LL, Murillo JN del P, Martínez M del CEA, Floréz-Ibarra JM. Experiencias de telesalud en un hospital especializado en salud mental durante la pandemia de COVID-19 en Perú. Rev Peru Med Exp Salud Publica. 2021;38(4):653–9. Doi: 10.17843/RPMESP.2021.384.9220.
Seguro Social Perú (EsSalud), Centro Nacional de Telemedicina (CENATE). Manual de Procesos y Procedimientos del Proceso de Telemedicina [Internet]. 2020 [citado el 28 de diciembre de 2021]. Disponible en: https://bit.ly/3E915zI
Eberly LA, Kallan MJ, Julien HM, Haynes N, Khatana SAM, Nathan AS, et al. Patient Characteristics Associated With Telemedicine Access for Primary and Specialty Ambulatory Care During the COVID-19 Pandemic. JAMA Netw Open. 2020;3(12):e2031640. Doi:10.1001/JAMANETWORKOPEN.2020.31640.
Instituto Nacional de Estadística e Informática Perú (INEI). Acceso de los hogares a las Tecnologías de Información y Comunicación (TIC) [Internet]. Lima; 2021 [citado el 4 de febrero de 2022]. Disponible en: https://bit.ly/3zVuTxl
Paredes-Noguni SR, Castro-Uriol DA, Salas-Rojas RM, Soto-Becerra P, Beltrán-Gárate BE, Paredes-Noguni SR, et al. Teleconsulta en oncología: experiencia en un hospital del Perú durante la pandemia. Rev Peru Med Exp Salud Publica. 2021;38(1):178–9. Doi: 10.17843/RPMESP.2021.381.6237.
Ramirez AV, Ojeaga M, Espinoza V, Hensler B, Honrubia V. Telemedicine in Minority and Socioeconomically Disadvantaged Communities Amidst COVID-19 Pandemic. Otolaryngol Neck Surg. 2021;164(1):91–2. Doi: 10.1177/0194599820947667.
Haynes SC, Kompala T, Neinstein A, Rosenthal J, Crossen S. Disparities in Telemedicine Use for Subspecialty Diabetes Care During COVID-19 Shelter-In-Place Orders. J Diabetes Sci Technol. 2021;15(5):986–92. Doi: 10.1177/1932296821997851.
Banerjee M, Chakraborty S, Pal R. Teleconsultation and Diabetes Care Amid COVID-19 Pandemic in India: Scopes and Challenges. J Diabetes Sci Technol. 2020;14(4):714–5. Doi: 10.1177/1932296820929391.
Wild SH, Hanley J, Lewis SC, McKnight JA, McCloughan LB, Padfield PL, et al. Supported Telemonitoring and Glycemic Control in People with Type 2 Diabetes: The Telescot Diabetes Pragmatic Multicenter Randomized Controlled Trial. PLoS Med. 2016;13(7). Doi: 10.1371/journal.pmed.1002098.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Eddy Lopez Huamanrayme, Elizabeth Salsavilca-Macavilca, Alvaro Taype-Rondan
This work is licensed under a Creative Commons Attribution 4.0 International License.